DUBLIN--(BUSINESS WIRE)--The "Vascular Closure Devices Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering.
The vascular closure devices market is projected to grow at a CAGR of 9.98% to reach US$2.903 billion by 2024, from US$1.641 billion in 2018.
The market is expected to show significant growth during the forecast period. The growth in vascular closure devices market may be attributed to the rising prevalence of cardiovascular diseases globally. As per data by WHO, cardiovascular diseases are leading cause of death globally with an estimated 17.9 million people dying of CVDs in 2016.
Reduced risk of vascular complications after the use of vascular closure devices will also boost the market through to 2024. However, high cost of vascular closure devices and the risk of Vascular Closure Device-Related Complications Might Restrict the market for vascular closure devices during the given time frame.
This report is an exhaustive study that aims to present the key market trends through various chapters focusing on different aspects of the market. The study provides a detailed market overview through the market dynamics sections which detail key market, drivers, restraints, and opportunities in the current market. The report analyzes key opportunity regional markets, and the current technology penetration through lifecycle analysis. The report also analyzes the market through comprehensive market segmentation by access, type, modality, end-user, and geography.
On the basis of access, the market is segmented as femoral access and radial access. Based on type, the market has been segmented as passive vascular closure devices and active vascular closure devices. Based on end-users, the market has been segmented as hospitals and clinics and ambulatory surgical centers.
Regional analysis has been provided with detailed analysis and forecast for the period 2019 to 2024. The global market has been broken down into North America, South America, Europe, Middle East and Africa, and Asia Pacific regions. The report also analyzes major countries across these regions with thorough analysis and forecast along with prevailing market trends and opportunities which each of these countries present for the manufacturers.
Major players in the Vascular Closure Devices market have been covered along with their relative competitive position and strategies. The report also mentions recent deals and investments of different market players over the last year. The company profiles section details the business overview, financial performance for the past three years, key products and services being offered along with the recent developments of these important players in Vascular Closure Devices market.
Key Topics Covered
1.1. Market Overview
1.2. Market Definition
1.3. Scope of the study
1.6. Base, and Forecast Years Timeline
2. Research methodology
2.1. Research Design
2.2. Secondary Sources
3. Executive Summary
4. Market Dynamics
4.1. Market Segmentation
4.2. Market Drivers
4.3. Market Restraints
4.4. Market Opportunities
4.5. Porter's Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness
5. Vascular Closure Devices Market by Access
5.1. Femoral Access
5.2. Radial Access
6. Vascular Closure Devices Market by Type
6.1. Passive Vascular Closure Devices
6.2. Active Vascular Closure Devices
7. Vascular Closure Devices Market by End Users
7.1. Hospitals & Clinics
7.2. Ambulatory Surgical Centres
8. Vascular Closure Devices Market by Geography
8.1. North America
8.2. South America
8.4. Middle East and Africa
8.4.2. Saudi Arabia
8.5. Asia Pacific
9. Competitive intelligence
9.1. Competitive Benchmarking and Analysis
9.2. Strategies of Key Players
9.3. Recent Investments and Deals
10. Company Profile
10.5. Vivasure Medical Ltd.
10.6. Essential Medical Inc.
10.8. InSeal Medical
10.9. Cardiva Medical Inc.
10.10. Vasorum Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/st32k